| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1594 | |
| Phytochemical name or plant extracts | Kaempferol 3-O-β-D-rutinoside | |
| PMID | 33064762 | |
| Literature evidence | Aldose reductase inhibitor form Cassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Extract | |
| Source of phytochemicals or plant Extracts | Cassia glauca | |
| Geographical availability | Assam, Bangladesh, Cambodia, East Himalaya, India, Laos, Myanmar, Northern Territory, Queensland, Sri Lanka, Thailand, Vietnam, West Himalaya, Western Australia | |
| Plant parts | Leaves | |
| Other cancers | Breast cancer, Liver cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 4.6±0.038 µg/ml against MCF-7 | |
| Potency | Kaempferol 3-O-β-D-rutinoside could be used in combination with chemotherapeutic drugs to increase the sensitivity to their cytotoxic activity and protect against their side effects. | |
| Cell line/ mice model | MCF-7, HepG-2 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:234675-2 | |
| Safety | NA |